BridgeBio Pharma is dedicated to developing breakthrough medicines for genetic diseases by bridging scientific advancements with commercial viability. The company focuses on treating underserved patient populations through innovative drug development and a commitment to fostering passionate, driven leaders in the field.
Mavericks are sought after for their experience in bringing together projects and promising research from academia to create life-changing medicines for rare disease patients. The organization focuses on Transthyretin Amyloid Cardiomyopathy (ATTR-CM) and values innovation, collaboration, and employee growth. They offer a remote opportunity within a dynamic environment.
BridgeBio Pharma is dedicated to developing breakthrough medicines for genetic diseases by bridging scientific advancements with commercial viability. The company focuses on treating underserved patient populations through innovative drug development and a commitment to fostering passionate, driven leaders in the field.
BridgeBio Pharma